Concepedia

Sunil Mistry

SM

Statistics

Publications

10

Citations

1.8K

H-Index

10

Active since

2012

Affiliations

Stanford University(Current)

South London and Maudsley NHS Foundation Trust

GlaxoSmithKline (United Kingdom)

Columbia University

GlaxoSmithKline (United States)

Sunil Mistry is an author at Stanford University specializing in pharmacology, pharmacy, and psychopharmacology.

Publications per year

2012–2025

10

Publications

10

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez et al. · New England Journal of Medicine · 2022 · 1.1K citations · Full text

, , +16

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez et al. · Journal of Affective Disorders · 2023 · 165 citations · Full text

, , +17

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

Guy M. Goodwin, Megan Croal, David Feifel et al. · Neuropsychopharmacology · 2023 · 164 citations · Full text

, , +17

Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis

Richard B. Moss, Sunil Mistry, Michael W. Konstan et al. · Journal of Cystic Fibrosis · 2012 · 112 citations · Full text

, , +9

The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation

James Rucker, Lindsey Marwood, Riikka-Liisa Johanna Ajantaival et al. · Journal of Psychopharmacology · 2022 · 101 citations · Full text

, , +13

1–5 of 10